Sumitomo Pharma Co Ltd (OTCPK:DNPUF)
$ 4.3 0 (0%) Market Cap: 1.52 Bil Enterprise Value: 3.31 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 64/100

Sumitomo Dainippon Pharma Co Ltd Sumitovant Presentation Transcript

Mar 23, 2021 / NTS GMT
Release Date Price: $18.75

Mar 23, 2021 / NTS GMT
Presentation
Mar 23, 2021 / NTS GMT

=====================
Corporate Participants
=====================
* Adele M. Gulfo
Myovant Sciences Ltd. - Interim Chief Commercial Officer & Director
* Bill McMahon
* Dan Rothman
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Hiroyuki Baba
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer of Global Data Design Office
* Myrtle Potter
* Sam Azoulay
* Toru Kimura
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer, Chief Scientific Officer & Director

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot